Glucagon (19-29) (human, rat, porcine)

Description:

It is likely to be the active peptide involved in the inhibition of the liver Ca²⁺ pump.

Sequence:

AQDFVQWLMNT

General

References

Comments (0)

Name	Glucagon (19-29) (human, rat, porcine)
Category	Glucagons and Glucagon-Like Peptides (GLP-1 and GLP-2)
One Letter Code	AQDFVQWLMNT
Three Letter Code	{Ala}{Gln}{Asp}{Phe}{Val}{Gln}{Trp}{Leu}{Met}{Asn}{Thr}
Molecular Weight	1352.530
Application	Diabetes

Vessey, Kirstan A., David A. Rushforth, and William K. Stell. "Glucagon-and secretin-related peptides differentially alter ocular growth and the development of form-deprivation myopia in chicks." Investigative ophthalmology & visual science 46.11 (2005): 3932-3942.

Bataille, Dominique, et al. "The Glucagon–Miniglucagon Interplay: A New Level in the Metabolic Regulation." Annals of the New York Academy of Sciences 1070.1 (2006): 161-166.

Dalle, Stéphane, et al. "Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology." Diabetes 51.2 (2002): 406-412.